Is Guideline-adherent Prescribing Associated with Quality of Life in Patients with Type 2 Diabetes?

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Aug 17

PMID 30114242

Citations 3

Authors

Kirsten P J Smits

Grigory Sidorenkov

Nanne Kleefstra

Steven H Hendriks

Margriet Bouma

Marianne Meulepas

Gerjan Navis

Henk J G Bilo

Petra Denig

Affiliations

Soon will be listed here.

Abstract

Background: Guideline-adherent prescribing for treatment of multiple risk factors in type 2 diabetes (T2D) patients is expected to improve clinical outcomes. However, the relationship to Health-Related Quality of Life (HRQoL) is not straightforward since guideline-adherent prescribing can increase medication burden.

Objectives: To test whether guideline-adherent prescribing and disease-specific medication burden are associated with HRQoL in patients with T2D.

Methods: Cross-sectional study including 1,044 T2D patients from the e-VitaDM/ZODIAC study in 2012 in the Netherlands. Data from the diabetes visit, such as laboratory and physical examinations and prescribed medication, and from two HRQoL questionnaires, the EuroQol 5 Dimensions 3 Levels (EQ5D-3L) and the World Health Organization Well-Being Index (WHO-5) were collected. Twenty indicators assessing prescribing of recommended glucose lowering drugs, statins, antihypertensives and renin-angiotensin-aldosterone system (RAAS)-inhibitors and potentially inappropriate drugs from a validated diabetes indicator set were included. Disease-specific medication burden was assessed using a modified version of the Medication Regimen Complexity Index (MRCI). Associations were tested with regression models, adjusting for age, gender, diabetes duration, comorbidity, body mass index and smoking.

Results: The mean MRCI was 7.1, the median EQ5D-3L-score was 0.86 and the mean WHO-5 score was 72. Seven indicators included too few patients and were excluded from the analysis. The remaining thirteen indicators focusing on recommended start, intensification, current and preferred use of glucose lowering drugs, statins, antihypertensives, RAAS inhibitors, and on inappropriate prescribing of glibenclamide and dual RAAS blockade were not significantly associated with HRQoL. Finally, also the MRCI was not associated with HRQoL.

Conclusions: We found no evidence for associations between guideline-adherent prescribing or disease-specific medication burden and HRQoL in T2D patients. This gives no rise to refrain from prescribing intensive treatment in T2D patients as recommended, but the interpretation of these results is limited by the cross-sectional study design and the selection of patients included in some indicators.

Citing Articles

Association Between Quality of Life and Drug Adherence Among Patients With Diabetes in India.

Chaudhari H, Ganguly B, Mirza N Cureus. 2024; 16(10):e71300.

PMID: 39529774 PMC: 11552205. DOI: 10.7759/cureus.71300.

Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression.

Wang Y, Xu Y, Shan H, Pan H, Chen J, Yang J Health Qual Life Outcomes. 2024; 22(1):74.

PMID: 39244536 PMC: 11380328. DOI: 10.1186/s12955-024-02288-1.

Association between medication adherence and health-related quality of life of patients with diabetes.

Chantzaras A, Yfantopoulos J Hormones (Athens). 2022; 21(4):691-705.

PMID: 36219341 PMC: 9552716. DOI: 10.1007/s42000-022-00400-y.

References

Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

Johnell K, Klarin I . The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007; 30(10):911-8. DOI: 10.2165/00002018-200730100-00009. View

Frohlich S, Zaccolo A, da Silva S, Mengue S . Association between drug prescribing and quality of life in primary care. Pharm World Sci. 2010; 32(6):744-51. DOI: 10.1007/s11096-010-9431-8. View

Black J, Long G, Sharp S, Kuznetsov L, Boothby C, Griffin S . Change in cardio-protective medication and health-related quality of life after diagnosis of screen-detected diabetes: Results from the ADDITION-Cambridge cohort. Diabetes Res Clin Pract. 2015; 109(1):170-7. PMC: 4504034. DOI: 10.1016/j.diabres.2015.04.013. View

Roelofsen Y, Hendriks S, Sieverink F, van Vugt M, van Hateren K, Snoek F . Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40). BMC Endocr Disord. 2014; 14:22. PMC: 4016215. DOI: 10.1186/1472-6823-14-22. View

Venskutonyte L, Brismar K, Ryden-Bergsten T, Ryden L, Kjellstrom B . Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: a DIGAMI2 QoL sub-study. Diab Vasc Dis Res. 2012; 10(3):263-9. DOI: 10.1177/1479164112463711. View

Meid A, Quinzler R, Groll A, Wild B, Saum K, Schottker B . Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. Eur J Clin Pharmacol. 2016; 72(7):877-85. DOI: 10.1007/s00228-016-2047-8. View

Menard J, Payette H, Dubuc N, Baillargeon J, Maheux P, Ardilouze J . Quality of life in type 2 diabetes patients under intensive multitherapy. Diabetes Metab. 2007; 33(1):54-60. DOI: 10.1016/j.diabet.2006.09.001. View

Smits K, Sidorenkov G, Kleefstra N, Bouma M, Meulepas M, Voorham J . Development and validation of prescribing quality indicators for patients with type 2 diabetes. Int J Clin Pract. 2016; 71(1). DOI: 10.1111/ijcp.12922. View

10.

Juola A, Pylkkanen S, Kautiainen H, Bell J, Bjorkman M, Finne-Soveri H . Burden of Potentially Harmful Medications and the Association With Quality of Life and Mortality Among Institutionalized Older People. J Am Med Dir Assoc. 2016; 17(3):276.e9-14. DOI: 10.1016/j.jamda.2015.12.011. View

11.

Li C, Ford E, Mokdad A, Jiles R, Giles W . Clustering of multiple healthy lifestyle habits and health-related quality of life among U.S. adults with diabetes. Diabetes Care. 2007; 30(7):1770-6. DOI: 10.2337/dc06-2571. View

12.

Chiu Y, Teitelbaum I, Misra M, de Leon E, Adzize T, Mehrotra R . Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009; 4(6):1089-96. PMC: 2689877. DOI: 10.2215/CJN.00290109. View

13.

Scheifes A, Walraven S, Stolker J, Nijman H, Egberts T, Heerdink E . Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Res Dev Disabil. 2015; 49-50:13-21. DOI: 10.1016/j.ridd.2015.11.017. View

14.

Schunk M, Reitmeir P, Schipf S, Volzke H, Meisinger C, Ladwig K . Health-related quality of life in women and men with type 2 diabetes: a comparison across treatment groups. J Diabetes Complications. 2014; 29(2):203-11. DOI: 10.1016/j.jdiacomp.2014.11.010. View

15.

Topp C, Ostergaard S, Sondergaard S, Bech P . The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015; 84(3):167-76. DOI: 10.1159/000376585. View

16.

Redekop W, Koopmanschap M, Stolk R, Rutten G, Wolffenbuttel B, Niessen L . Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002; 25(3):458-63. DOI: 10.2337/diacare.25.3.458. View

17.

George J, Phun Y, Bailey M, Kong D, Stewart K . Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004; 38(9):1369-76. DOI: 10.1345/aph.1D479. View

18.

Smits K, Sidorenkov G, Navis G, Bouma M, Meulepas M, Bilo H . Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2017; 40(7):e83-e84. DOI: 10.2337/dc17-0236. View

19.

Wasem J, Bramlage P, Gitt A, Binz C, Krekler M, Deeg E . Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registry. Cardiovasc Diabetol. 2013; 12:47. PMC: 3606825. DOI: 10.1186/1475-2840-12-47. View

20.

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp F, Denig P . Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?. PLoS One. 2013; 8(10):e78821. PMC: 3813585. DOI: 10.1371/journal.pone.0078821. View